DF MMP-3 ELISA

Product Details :

The new Aeskulisa DF MMP-3 is used as an activity and early prognostic marker for the development of bone erosions in rheumatoid arthritis.

MMP-3 is directly involved in cartilage and bone degradation in RA. It has also been shown to predict bone erosions in early RA patients 6 to 12 months in advance. Serum levels of RA patients are strongly elevated and correlate with the amount of MMP-3 in the synovial fluid. It helps monitoring disease activity since it offers a faster and cheaper option to the assessment of clinical activity than using activity scores like DAS, DAS28, SDAI or CDAI.